| AGEs | Advanced glycation end products |
| AL | Axial length |
| AMD | Age-related macular degeneration |
| BDNF | Brain-derived neurotrophic factor |
| COX-2 | Cyclooxygenase-2 |
| CRN | Council for Responsible Nutrition |
| DR | Diabetic retinopathy |
| ERG | Electroretinogram |
| ERK | Extracellular signal-regulated kinase |
| FDA | US Food and Drug Administration |
| GGPP | Geranylgeranyl pyrophosphate |
| GPx | Glutathione peroxidase |
| GRAS | Generally Regarded as Safe |
| GSH | Glutathione |
| HbA1c | Hemoglobin A1c |
| HDL | High-density lipoproteins |
| IGF-1 | Insulin-like growth factor-1 |
| IL-1β | Interleukin 1β |
| iNOS | Inducible nitric oxide synthase |
| IRMA | Intraretinal microvascular abnormalities |
| LASIK | Laser Assisted in situ Keratomileusis |
| LDL | Low-density lipoproteins |
| mfERG | Multifocal electroretinography |
| MPOD | Macular pigment optical density |
| NF-κB | Nuclear factor-kappa B |
| NPDR | Non-proliferative diabetic retinopathy |
| OCT | Optical coherence tomography |
| OIR | Oxygen-Induced Retinopathy |
| PDR | Proliferative diabetic retinopathy |
| ROP | Retinopathy of prematurity |
| ROS | Reactive oxygen species |
| RPE | Retinal pigment epithelium |
| SMILE | Small Incision Lenticule Extraction |
| VLDL | Very-low-density lipoproteins |